Sowell Financial Services LLC Stealth Bio Therapeutics Corp Transaction History

Sowell Financial Services LLC

  • $2.1 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
$1.07 - $1.77 $3,144 - $5,202
-2,939 Closed
0 $0
Q4 2020

Jan 13, 2021
BUY
$1.27 - $1.62 $3,732 - $4,761
2,939 New
2,939 $4,000

Others Institutions Holding MITO

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0
View Full List

About Stealth BioTherapeutics Corp

MITO Quotes by TradingView
  • Ticker MITO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,548,600
  • Description
  • Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duche...
More about MITO
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email